Key Insights
The Italy diabetes care devices market, valued at €1.03 billion in 2025, is projected to experience robust growth, driven by a rising prevalence of diabetes, an aging population, and increasing awareness of advanced diabetes management techniques. The market's Compound Annual Growth Rate (CAGR) of 6.70% from 2025 to 2033 indicates a significant expansion. Key drivers include the increasing adoption of continuous glucose monitoring (CGM) systems, offering patients greater convenience and improved glycemic control. Furthermore, technological advancements in insulin delivery systems, such as the growing popularity of insulin pumps and disposable pens, contribute to market growth. However, the high cost of advanced devices and potential reimbursement challenges pose restraints. Market segmentation reveals a substantial share held by management devices (insulin pumps, syringes, pens, jet injectors), followed by monitoring devices (self-monitoring blood glucose meters and CGMs), and lancets. Leading companies like Medtronic, Roche Diabetes Care, Novo Nordisk, and Abbott Diabetes Care are shaping market dynamics through product innovation and strategic partnerships. The expanding geriatric population in Italy further fuels demand, particularly for user-friendly and reliable devices. Future growth will depend on continued technological innovation, government initiatives supporting diabetes care, and affordability improvements for advanced technologies.
The market's forecast period of 2025-2033 demonstrates strong potential for sustained growth. The increasing adoption of CGM systems is expected to be a major catalyst. Furthermore, the evolving landscape of diabetes management, with a greater emphasis on preventative care and personalized treatment plans, presents significant opportunities for manufacturers to develop and introduce innovative products. The competitive landscape is intense, with established players constantly striving for market share through research and development, mergers and acquisitions, and strategic collaborations. The Italian healthcare system's approach to reimbursement policies will play a crucial role in determining the accessibility and affordability of these advanced diabetes management tools, ultimately impacting the market's trajectory during the forecast period.

Italy Diabetes Care Devices Industry Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the Italy diabetes care devices market, offering invaluable insights for industry professionals, investors, and strategists. Covering the period 2019-2033, with a focus on 2025, this report meticulously examines market structure, dynamics, leading players, and future growth prospects. The report utilizes data-driven analysis to present actionable information, crucial for navigating the evolving landscape of diabetes care in Italy.
Italy Diabetes Care Devices Industry Market Structure & Innovation Trends
The Italian diabetes care devices market exhibits a moderately concentrated structure, with several multinational corporations holding significant market share. Key players like Roche Diabetes Care, Sanofi, Eli Lilly, Novo Nordisk A/S, and Medtronic dominate the landscape, competing intensely on innovation and product differentiation. Market share data for 2024 estimates these companies hold approximately xx% collectively. The market is driven by technological advancements, particularly in continuous glucose monitoring (CGM) and insulin pump technology. Regulatory frameworks, aligned with EU directives, influence product approvals and market access. The presence of substitute therapies, such as lifestyle modifications and oral medications, also shapes market dynamics. End-user demographics, characterized by an aging population and rising diabetes prevalence, significantly contribute to market growth. M&A activity remains relatively modest in recent years, with a total estimated value of xx Million in deals over the historical period (2019-2024).
- Market Concentration: Moderately concentrated
- Innovation Drivers: CGM, Insulin pump technology
- Regulatory Framework: EU-aligned
- M&A Activity (2019-2024): Estimated xx Million

Italy Diabetes Care Devices Industry Market Dynamics & Trends
The Italian diabetes care devices market is experiencing robust growth, driven primarily by increasing diabetes prevalence, rising healthcare expenditure, and expanding access to advanced technologies. The CAGR for the forecast period (2025-2033) is projected at xx%. Technological disruptions, particularly the proliferation of CGM systems, are transforming patient management and improving treatment outcomes. Consumer preferences are shifting towards convenient, user-friendly devices with improved accuracy and connectivity features. Competitive dynamics are characterized by intense rivalry amongst established players and the emergence of innovative startups. Market penetration of CGM devices is expected to reach xx% by 2033, reflecting a significant increase from the current level. This growth is fueled by the rising demand for convenient self-management solutions.

Dominant Regions & Segments in Italy Diabetes Care Devices Industry
While data for specific regional dominance within Italy is not readily available, the northern regions (e.g., Lombardy, Veneto) are likely to lead due to higher population density and economic development, consequently offering greater access to advanced healthcare technologies.
Dominant Segments:
- Management Devices: Insulin pumps are expected to dominate due to their ability to automate insulin delivery.
- Monitoring Devices: Continuous Glucose Monitoring (CGM) is experiencing rapid growth due to its ability to provide real-time data. Self-monitoring blood glucose (SMBG) remains a significant segment, though with slower growth relative to CGM.
Key Drivers:
- Economic Policies: Government initiatives supporting healthcare access and technological adoption influence market growth.
- Healthcare Infrastructure: Robust healthcare infrastructure facilitates the distribution and adoption of advanced devices.
Italy Diabetes Care Devices Industry Product Innovations
Recent product developments highlight a trend towards miniaturization, improved accuracy, enhanced connectivity, and user-friendly interfaces. The launch of Cequr's Insulin Pen 2.0TM in June 2022 and Roche's new point-of-care blood glucose monitor in January 2022 exemplify this trend. These innovations aim to improve patient adherence, reduce the burden of diabetes management, and ultimately improve clinical outcomes. The market fit for these products is strong, driven by the unmet needs of patients and healthcare professionals for more convenient and effective solutions.
Report Scope & Segmentation Analysis
This report comprehensively segments the Italian diabetes care devices market into management and monitoring devices.
Management Devices:
- Insulin Pumps: This segment is projected to grow at a CAGR of xx% during the forecast period, driven by technological advancements and increasing patient preference.
- Infusion Sets: This market is largely dependent on the insulin pump market.
- Insulin Syringes: A mature market with steady growth.
- Cartridges in Reusable Pens: This segment benefits from convenience but faces competition from disposable pens.
- Insulin Disposable Pens: High market share due to ease of use.
- Jet Injectors: A niche market with limited growth.
Monitoring Devices:
- Self-monitoring Blood Glucose (SMBG): A mature market with steady growth despite competition from CGM.
- Continuous Glucose Monitoring (CGM): This segment is characterized by rapid growth, driven by technological advancements and increasing patient adoption.
- Lancets: This segment maintains steady demand due to continued SMBG use.
Key Drivers of Italy Diabetes Care Devices Industry Growth
The Italian diabetes care devices market is primarily driven by:
- Rising Prevalence of Diabetes: Italy's aging population contributes to the increasing number of diabetes patients.
- Technological Advancements: Innovations like CGM systems improve disease management.
- Government Initiatives: Healthcare policies supporting diabetes care drive market growth.
Challenges in the Italy Diabetes Care Devices Industry Sector
Challenges include:
- High Device Costs: The high cost of advanced devices limits access for some patients.
- Reimbursement Policies: Complex reimbursement processes can hinder market penetration.
- Intense Competition: Competition from established players and new entrants creates pricing pressure.
Emerging Opportunities in Italy Diabetes Care Devices Industry
Opportunities exist in:
- Expansion of CGM adoption: Increased awareness and improved reimbursement policies could drive CGM penetration.
- Development of integrated solutions: Devices with connected features and data analytics could enhance diabetes management.
- Telemedicine integration: Remote monitoring and virtual consultations could improve patient access to care.
Leading Players in the Italy Diabetes Care Devices Industry Market
- Insulin Devices
- Rossmax International Ltd
- Roche Diabetes Care
- Sanofi
- Eli Lilly
- Novo Nordisk A/S
- LifeScan Inc
- Abbott Diabetes Care
- Medtronic
- Dexcom
- Arkray Inc
- Ascensia Diabetes Care
- Insulet Corporation
Key Developments in Italy Diabetes Care Devices Industry
- June 2022: Cequr launched its Insulin Pen 2.0TM, a wearable insulin delivery device with an integrated blood glucose meter. This significantly impacts the market by introducing a more convenient and user-friendly technology.
- January 2022: Roche launched its Cobas pulse point-of-care blood glucose monitor, offering improved diagnostic capabilities for hospital professionals. This enhances hospital efficiency and patient care.
Future Outlook for Italy Diabetes Care Devices Industry Market
The Italian diabetes care devices market is poised for continued growth, driven by increasing diabetes prevalence, technological advancements, and supportive government policies. Strategic opportunities exist for companies focusing on innovative products, improved accessibility, and integrated solutions, enhancing patient care and streamlining treatment processes. The market is expected to see significant expansion in CGM adoption and continued innovation in insulin delivery systems.
Italy Diabetes Care Devices Industry Segmentation
-
1. Management Devices
-
1.1. Insulin Pump
- 1.1.1. Insulin Pump Device
- 1.1.2. Insulin Pump Reservoir
- 1.1.3. Infusion Set
- 1.2. Insulin Syringes
- 1.3. Cartridges in Reusable Pens
- 1.4. Insulin Disposable Pens
- 1.5. Jet Injectors
-
1.1. Insulin Pump
-
2. Monitoring Devices
-
2.1. Self-monitoring Blood Glucose
- 2.1.1. Glucometer Devices
- 2.1.2. Blood Glucose Test Strips
- 2.1.3. Lancets
-
2.2. Continuous Glucose Monitoring
- 2.2.1. Sensors
- 2.2.2. Durables
-
2.1. Self-monitoring Blood Glucose
Italy Diabetes Care Devices Industry Segmentation By Geography
- 1. Italy

Italy Diabetes Care Devices Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.70% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Italy Diabetes Care Devices Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 5.1.1. Insulin Pump
- 5.1.1.1. Insulin Pump Device
- 5.1.1.2. Insulin Pump Reservoir
- 5.1.1.3. Infusion Set
- 5.1.2. Insulin Syringes
- 5.1.3. Cartridges in Reusable Pens
- 5.1.4. Insulin Disposable Pens
- 5.1.5. Jet Injectors
- 5.1.1. Insulin Pump
- 5.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.2.1. Self-monitoring Blood Glucose
- 5.2.1.1. Glucometer Devices
- 5.2.1.2. Blood Glucose Test Strips
- 5.2.1.3. Lancets
- 5.2.2. Continuous Glucose Monitoring
- 5.2.2.1. Sensors
- 5.2.2.2. Durables
- 5.2.1. Self-monitoring Blood Glucose
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Italy
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Insulin Devices
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Rossmax International Ltd
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Roche Diabetes Care
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Sanofi
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Eli Lilly
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Novo Nordisk A/S
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 LifeScan Inc
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Abbott Diabetes Care
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Medtronic
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Dexcom
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 Arkray Inc
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.12 Ascensia Diabetes Care
- 6.2.12.1. Overview
- 6.2.12.2. Products
- 6.2.12.3. SWOT Analysis
- 6.2.12.4. Recent Developments
- 6.2.12.5. Financials (Based on Availability)
- 6.2.13 Insulet Corporation
- 6.2.13.1. Overview
- 6.2.13.2. Products
- 6.2.13.3. SWOT Analysis
- 6.2.13.4. Recent Developments
- 6.2.13.5. Financials (Based on Availability)
- 6.2.1 Insulin Devices
List of Figures
- Figure 1: Italy Diabetes Care Devices Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Italy Diabetes Care Devices Industry Share (%) by Company 2024
List of Tables
- Table 1: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2019 & 2032
- Table 5: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 6: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2019 & 2032
- Table 7: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 8: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Region 2019 & 2032
- Table 9: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 10: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2019 & 2032
- Table 11: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 12: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2019 & 2032
- Table 13: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 14: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2019 & 2032
- Table 15: Italy Diabetes Care Devices Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 16: Italy Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Italy Diabetes Care Devices Industry?
The projected CAGR is approximately 6.70%.
2. Which companies are prominent players in the Italy Diabetes Care Devices Industry?
Key companies in the market include Insulin Devices, Rossmax International Ltd , Roche Diabetes Care, Sanofi, Eli Lilly, Novo Nordisk A/S, LifeScan Inc, Abbott Diabetes Care, Medtronic, Dexcom, Arkray Inc, Ascensia Diabetes Care, Insulet Corporation.
3. What are the main segments of the Italy Diabetes Care Devices Industry?
The market segments include Management Devices, Monitoring Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 1.03 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
June 2022: Cequr, the leader in wearable diabetes technology, released their newest and most innovative insulin delivery device yet, the Insulin Pen 2.0TM. The pen is small enough to be always worn on the user's body. It also features a built-in blood glucose meter so users can track their blood sugar throughout the day.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Italy Diabetes Care Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Italy Diabetes Care Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Italy Diabetes Care Devices Industry?
To stay informed about further developments, trends, and reports in the Italy Diabetes Care Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence